Strategic Partnerships MyOme is expanding access through collaborations with industry players like Natera and Thatch Health, presenting a sales angle to offer integrated genomics-based risk assessment and proactive health reports via partner ecosystems.

Clinical Expansion With Zenith powered by MyOme and participation in ACMG 2026, there is a clear opportunity to pitch expanded diagnostic capabilities and long-read methylation analysis to clinics and hospitals seeking advanced rare disease diagnostics.

Proactive Health Network The launch of the Proactive Health Network creates a channel to engage concierge and executive health clinics focused on proactive management, enabling a B2B to reach high-value patients with personalized genomic insights.

Polygenic Risk Value MyOme’s emphasis on polygenic risk modeling suggests opportunities to offer risk stratification services, lifestyle and preventive guidance programs, and data-driven care pathways to payers and health systems seeking preventive care monetization.

Scale through Accessibility Recent capabilities to broaden patient access align with selling services that integrate MyOme reports into existing clinical workflows, EHR-ready formats, and partner platforms to scale precision medicine offerings.